Latest Investigational Device Exemption Stories
IDE approval follows recent CE Mark approval, with initial EU/Asia Pacific commercialization to begin in 2015 MOUNTAIN VIEW, Calif., March 18, 2015 /PRNewswire/ -- Simplify Medical,
ALISO VIEJO, Calif., Feb. 12, 2015 /PRNewswire/ -- Sequent Medical announced today that the U.S.
MONMOUTH JUNCTION, N.J., Dec.
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Gastrointestinal Resections PITTSBURGH, Dec.
Based on the results of the trial's pre-specified interim analysis all control patients in the EF-14 phase III trial will be offered the opportunity to cross over to receive Tumor Treating Fields
ALISO VIEJO, Calif., Aug. 28, 2014 /PRNewswire/ -- Sequent Medical, Inc.
SAN JOSE, Calif., June 10, 2014 /PRNewswire/ -- Pulsar Vascular, the innovator and developer of the PulseRider®, a minimally invasive, aneurysm neck reconstruction device,
SINGAPORE, May 5, 2014 /PRNewswire/ -- Biosensors International Group, Ltd.
DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t45c8d/fda_approval) has announced the addition of the "FDA Approval
Results provide significant support to advance i-FACTOR(TM) Peptide Enhanced Bone Graft for FDA regulatory review. WESTMINSTER, Colo., March 11, 2014 /PRNewswire/ -- Cerapedics, Inc.,
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.